• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯类耐药肺炎克雷伯菌临床分离株(NDM-4)的蛋白质组学分析:探索耐药机制及潜在药物靶标

Proteome profiling of carbapenem-resistant K. pneumoniae clinical isolate (NDM-4): Exploring the mechanism of resistance and potential drug targets.

机构信息

Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.

Department of Biophysics, University of Delhi South Campus, India.

出版信息

J Proteomics. 2019 May 30;200:102-110. doi: 10.1016/j.jprot.2019.04.003. Epub 2019 Apr 3.

DOI:10.1016/j.jprot.2019.04.003
PMID:30953729
Abstract

The emergence of carbapenem resistance has become a major problem worldwide. This has made treatment of K. pneumoniae infections a difficult task. In this study, we have explored the whole proteome of the carbapenem-resistant Klebsiella pneumonia clinical isolate (NDM-4) under the meropenem stress. Proteomics (LC-MS/MS) and bioinformatics approaches were employed to uncover the novel mystery of the resistance over the existing mechanisms. Gene ontology, KEGG and STRING were used for functional annotation, pathway enrichment and protein-protein interaction (PPI) network respectively. LC-MS/MS analysis revealed that 52 proteins were overexpressed (≥10 log folds) under meropenem stress. These proteins belong to four major groups namely protein translational machinery complex, DNA/RNA modifying enzymes or proteins, proteins involved in carbapenems cleavage, modifications & transport and energy metabolism & intermediary metabolism-related proteins. Among the total 52 proteins 38 {matched to Klebsiella pneumonia subsp. pneumoniae (strain ATCC 700721/MGH 78578)} were used for functional annotation, pathways enrichment and protein-protein interaction. These were significantly enriched in the "intracellular" (14 of 38), "cytoplasm" (12 of 38) and "ribosome" (10 of 38). We suggest that these 52 over expressed proteins and their interactive proteins cumulatively contributed in survival of bacteria and meropenem resistance through various mechanisms or enriched pathways. These proteins targets and their pathways might be used for development of novel therapeutics against the resistance; therefore, the situation of the emergence of "bad-bugs" could be controlled.

摘要

碳青霉烯类耐药的出现已成为全球范围内的一个主要问题。这使得治疗肺炎克雷伯菌感染成为一项艰巨的任务。在这项研究中,我们在美罗培南应激下探索了碳青霉烯类耐药肺炎克雷伯菌临床分离株(NDM-4)的全蛋白质组。采用蛋白质组学(LC-MS/MS)和生物信息学方法来揭示现有机制之外的新型耐药机制。GO、KEGG 和 STRING 分别用于功能注释、通路富集和蛋白质-蛋白质相互作用(PPI)网络。LC-MS/MS 分析显示,在美罗培南应激下有 52 种蛋白质过度表达(≥10 log 倍)。这些蛋白质属于四个主要组,即蛋白质翻译机制复合物、DNA/RNA 修饰酶或蛋白质、参与碳青霉烯类药物切割、修饰和运输的蛋白质以及与能量代谢和中间代谢相关的蛋白质。在总共 52 种蛋白质中,有 38 种{与肺炎克雷伯亚种肺炎克雷伯菌(菌株 ATCC 700721/MGH 78578)匹配}用于功能注释、通路富集和蛋白质-蛋白质相互作用。这些蛋白质在“细胞内”(38 个中的 14 个)、“细胞质”(38 个中的 12 个)和“核糖体”(38 个中的 10 个)中显著富集。我们认为,这些过度表达的 52 种蛋白质及其相互作用蛋白通过各种机制或富集的途径共同促进了细菌的存活和对美罗培南的耐药性。这些蛋白质的靶点及其途径可能被用于开发针对耐药性的新型治疗方法;因此,可以控制“坏细菌”的出现情况。

相似文献

1
Proteome profiling of carbapenem-resistant K. pneumoniae clinical isolate (NDM-4): Exploring the mechanism of resistance and potential drug targets.碳青霉烯类耐药肺炎克雷伯菌临床分离株(NDM-4)的蛋白质组学分析:探索耐药机制及潜在药物靶标
J Proteomics. 2019 May 30;200:102-110. doi: 10.1016/j.jprot.2019.04.003. Epub 2019 Apr 3.
2
Down-Regulation of Flagellar, Fimbriae, and Pili Proteins in Carbapenem-Resistant (NDM-4) Clinical Isolates: A Novel Linkage to Drug Resistance.耐碳青霉烯类(NDM-4)临床分离株中鞭毛、菌毛和菌毛蛋白的下调:与耐药性的新联系。
Front Microbiol. 2019 Dec 17;10:2865. doi: 10.3389/fmicb.2019.02865. eCollection 2019.
3
Proteomic analysis of a carbapenem-resistant Klebsiella pneumoniae strain in response to meropenem stress.碳青霉烯类耐药肺炎克雷伯菌对美罗培南胁迫的蛋白质组学分析。
J Glob Antimicrob Resist. 2017 Mar;8:172-178. doi: 10.1016/j.jgar.2016.12.010. Epub 2017 Feb 20.
4
A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumonia strain PittNDM01.用于鉴定耐碳青霉烯类肺炎克雷伯菌株 PittNDM01 中新药物靶点的计算减法基因组分析。
Microb Pathog. 2020 Sep;146:104245. doi: 10.1016/j.micpath.2020.104245. Epub 2020 May 11.
5
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.韩国碳青霉烯类耐药肠杆菌科分离株的特征。
Diagn Microbiol Infect Dis. 2013 Aug;76(4):486-90. doi: 10.1016/j.diagmicrobio.2013.04.006. Epub 2013 May 18.
6
Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam.越南携带多种碳青霉烯酶(KPC-2、NDM-1、NDM-4和OXA-48)与16S rRNA甲基化酶(RmtB和RmtC)组合的耐碳青霉烯肺炎克雷伯菌临床分离株的传播情况。
BMC Infect Dis. 2017 Jul 4;17(1):467. doi: 10.1186/s12879-017-2570-y.
7
Emergence of Klebsiella pneumoniae ST273 Carrying bla and ST656 Carrying bla in Manila, Philippines.菲律宾马尼拉出现携带bla的肺炎克雷伯菌ST273和携带bla的ST656。
Microb Drug Resist. 2016 Oct;22(7):585-588. doi: 10.1089/mdr.2015.0205. Epub 2016 Mar 31.
8
Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.具有边缘型碳青霉烯类耐药的肺炎克雷伯菌分离株的耐药机制对碳青霉烯类药物接种物效应的影响。
Antimicrob Agents Chemother. 2015 Aug;59(8):5014-7. doi: 10.1128/AAC.00533-15. Epub 2015 May 18.
9
Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.土耳其患者分离出的耐碳青霉烯类肺炎克雷伯菌菌株中β-内酰胺酶基因的分布情况。
Ann Lab Med. 2015 Nov;35(6):595-601. doi: 10.3343/alm.2015.35.6.595.
10
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.耐碳青霉烯类肺炎克雷伯菌感染治疗期间因质粒介导的突变导致头孢他啶-阿维巴坦耐药的出现
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02097-16. Print 2017 Mar.

引用本文的文献

1
Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review.蛋白质组学对细菌抗生素反应的见解:一篇综述
Int J Mol Sci. 2025 Jul 27;26(15):7255. doi: 10.3390/ijms26157255.
2
Proteomic Analysis of Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Under Aminoglycoside Drug Pressure.氨基糖苷类药物压力下耐药结核分枝杆菌临床分离株的蛋白质组学分析
Curr Microbiol. 2025 Jul 3;82(8):361. doi: 10.1007/s00284-025-04341-8.
3
Deciphering Antibiotic-Targeted Metabolic Pathways in : Insights from Transcriptomics and Genome-Scale Metabolic Modeling.
解读抗生素靶向的代谢途径:转录组学和基因组规模代谢建模的见解
Life (Basel). 2024 Sep 2;14(9):1102. doi: 10.3390/life14091102.
4
Recombinant Actifensin and Defensin-d2 Induce Critical Changes in the Proteomes of Multidrug-Resistant Pseudomonas aeruginosa and Candida albicans.重组 Actifensin 和 Defensin-d2 诱导多重耐药铜绿假单胞菌和白念珠菌蛋白质组发生关键变化。
Microbiol Spectr. 2022 Oct 26;10(5):e0206222. doi: 10.1128/spectrum.02062-22. Epub 2022 Sep 22.
5
Molecular phenotyping approaches for the detection and monitoring of carbapenem-resistant Enterobacteriaceae by mass spectrometry.通过质谱法检测和监测耐碳青霉烯类肠杆菌科细菌的分子表型分析方法
J Mass Spectrom Adv Clin Lab. 2022 Sep 6;26:9-19. doi: 10.1016/j.jmsacl.2022.09.001. eCollection 2022 Nov.
6
Pathway Driven Target Selection in : Insights Into Carbapenem Exposure.基于作用途径的药物靶标选择:碳青霉烯类药物暴露的相关见解
Front Cell Infect Microbiol. 2022 Jan 31;12:773405. doi: 10.3389/fcimb.2022.773405. eCollection 2022.
7
Proteomic Characterization and Target Identification Against Streptococcus mutans Under Bacitracin Stress Conditions Using LC-MS and Subtractive Proteomics.使用 LC-MS 和消减蛋白质组学技术对抗生素杆菌素胁迫条件下变异链球菌的蛋白质组学特征分析和靶标鉴定
Protein J. 2022 Feb;41(1):166-178. doi: 10.1007/s10930-021-10038-1. Epub 2022 Jan 6.
8
Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal Resistance.利奈唑胺与磷霉素的协同组合缩小彼此的突变选择窗以预防肠球菌耐药性。
Front Microbiol. 2021 Feb 9;11:605962. doi: 10.3389/fmicb.2020.605962. eCollection 2020.
9
Anti-carbapenamase activity of essential oil against isolated carbapenem resistant (MN396685).精油对分离出的耐碳青霉烯类(MN396685)的抗碳青霉烯酶活性。
Saudi J Biol Sci. 2020 Sep;27(9):2269-2279. doi: 10.1016/j.sjbs.2020.06.044. Epub 2020 Jun 30.
10
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of .肠球菌的毒力特性、生物膜形成能力和抗生素耐药性。
Int J Environ Res Public Health. 2020 Aug 28;17(17):6278. doi: 10.3390/ijerph17176278.